Fluid resuscitation with hemoglobin vesicles prevents Escherichia coli growth via complement activation in a hemorrhagic shock rat model

Kazuaki Taguchi, Shigeru Ogaki, Hiroshi Watanabe, Daisuke Kadowaki, Hiromi Sakai, Koichi Kobayashi, Hirohisa Horinouchi, Toru Maruyama, Masaki Otagiri

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Hemoglobin vesicles (HbVs) could serve as a substitute for red blood cells (RBCs) in resuscitation from massive hemorrhage. A massive transfusion of RBCs can increase the risk of infection, which is not caused by contaminating micro-organisms in the transfused RBCs but by a breakdown of the host defense system. We previously found that complement activity was increased after resuscitation with HbVs at a putative dose in a rat model of hemorrhagic shock. It is known that complement system plays a key role in host defense in the embryonic stage. Therefore, the objective of this study was to address whether the suppression of bacterial infections in hemorrhagic shock rats was a result of increased complement activity after massive HbV transfusion. For this purpose, Escherichia coli were incubated with plasma samples obtained from a rat model of hemorrhagic shock resuscitated by HbVs or RBCs, and bacterial growth was determined under ex vivo conditions. As a result, E. coli growth was found to be suppressed by increased complement activity, mediated by the production of IgM from spleen. However, this antibacterial activity disappeared when the E. coli were treated with complement-inactivated plasma obtained from splenoctomized rats. In addition, the resuscitation of HbVs from hemorrhagic shock increased the survival rate and viable bacterial counts in blood in cecum ligation and puncture rats, a sepsis model. In conclusion, the resuscitation of HbVs in the rat model of hemorrhagic shock suppresses bacterial growth via complement activation induced by IgM.

Original languageEnglish
Pages (from-to)201-208
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume337
Issue number1
DOIs
Publication statusPublished - 2011 Apr 1
Externally publishedYes

Fingerprint

Hemorrhagic Shock
Complement Activation
Resuscitation
Hemoglobins
Escherichia coli
Growth
Erythrocytes
Immunoglobulin M
Erythrocyte Transfusion
Cecum
Bacterial Load
Punctures
Bacterial Infections
Ligation
Sepsis
Spleen
Hemorrhage
Infection

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Fluid resuscitation with hemoglobin vesicles prevents Escherichia coli growth via complement activation in a hemorrhagic shock rat model. / Taguchi, Kazuaki; Ogaki, Shigeru; Watanabe, Hiroshi; Kadowaki, Daisuke; Sakai, Hiromi; Kobayashi, Koichi; Horinouchi, Hirohisa; Maruyama, Toru; Otagiri, Masaki.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 337, No. 1, 01.04.2011, p. 201-208.

Research output: Contribution to journalArticle

Taguchi, K, Ogaki, S, Watanabe, H, Kadowaki, D, Sakai, H, Kobayashi, K, Horinouchi, H, Maruyama, T & Otagiri, M 2011, 'Fluid resuscitation with hemoglobin vesicles prevents Escherichia coli growth via complement activation in a hemorrhagic shock rat model', Journal of Pharmacology and Experimental Therapeutics, vol. 337, no. 1, pp. 201-208. https://doi.org/10.1124/jpet.110.177832
Taguchi, Kazuaki ; Ogaki, Shigeru ; Watanabe, Hiroshi ; Kadowaki, Daisuke ; Sakai, Hiromi ; Kobayashi, Koichi ; Horinouchi, Hirohisa ; Maruyama, Toru ; Otagiri, Masaki. / Fluid resuscitation with hemoglobin vesicles prevents Escherichia coli growth via complement activation in a hemorrhagic shock rat model. In: Journal of Pharmacology and Experimental Therapeutics. 2011 ; Vol. 337, No. 1. pp. 201-208.
@article{28bbee4d6c5845778a642c34d797c767,
title = "Fluid resuscitation with hemoglobin vesicles prevents Escherichia coli growth via complement activation in a hemorrhagic shock rat model",
abstract = "Hemoglobin vesicles (HbVs) could serve as a substitute for red blood cells (RBCs) in resuscitation from massive hemorrhage. A massive transfusion of RBCs can increase the risk of infection, which is not caused by contaminating micro-organisms in the transfused RBCs but by a breakdown of the host defense system. We previously found that complement activity was increased after resuscitation with HbVs at a putative dose in a rat model of hemorrhagic shock. It is known that complement system plays a key role in host defense in the embryonic stage. Therefore, the objective of this study was to address whether the suppression of bacterial infections in hemorrhagic shock rats was a result of increased complement activity after massive HbV transfusion. For this purpose, Escherichia coli were incubated with plasma samples obtained from a rat model of hemorrhagic shock resuscitated by HbVs or RBCs, and bacterial growth was determined under ex vivo conditions. As a result, E. coli growth was found to be suppressed by increased complement activity, mediated by the production of IgM from spleen. However, this antibacterial activity disappeared when the E. coli were treated with complement-inactivated plasma obtained from splenoctomized rats. In addition, the resuscitation of HbVs from hemorrhagic shock increased the survival rate and viable bacterial counts in blood in cecum ligation and puncture rats, a sepsis model. In conclusion, the resuscitation of HbVs in the rat model of hemorrhagic shock suppresses bacterial growth via complement activation induced by IgM.",
author = "Kazuaki Taguchi and Shigeru Ogaki and Hiroshi Watanabe and Daisuke Kadowaki and Hiromi Sakai and Koichi Kobayashi and Hirohisa Horinouchi and Toru Maruyama and Masaki Otagiri",
year = "2011",
month = "4",
day = "1",
doi = "10.1124/jpet.110.177832",
language = "English",
volume = "337",
pages = "201--208",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Fluid resuscitation with hemoglobin vesicles prevents Escherichia coli growth via complement activation in a hemorrhagic shock rat model

AU - Taguchi, Kazuaki

AU - Ogaki, Shigeru

AU - Watanabe, Hiroshi

AU - Kadowaki, Daisuke

AU - Sakai, Hiromi

AU - Kobayashi, Koichi

AU - Horinouchi, Hirohisa

AU - Maruyama, Toru

AU - Otagiri, Masaki

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Hemoglobin vesicles (HbVs) could serve as a substitute for red blood cells (RBCs) in resuscitation from massive hemorrhage. A massive transfusion of RBCs can increase the risk of infection, which is not caused by contaminating micro-organisms in the transfused RBCs but by a breakdown of the host defense system. We previously found that complement activity was increased after resuscitation with HbVs at a putative dose in a rat model of hemorrhagic shock. It is known that complement system plays a key role in host defense in the embryonic stage. Therefore, the objective of this study was to address whether the suppression of bacterial infections in hemorrhagic shock rats was a result of increased complement activity after massive HbV transfusion. For this purpose, Escherichia coli were incubated with plasma samples obtained from a rat model of hemorrhagic shock resuscitated by HbVs or RBCs, and bacterial growth was determined under ex vivo conditions. As a result, E. coli growth was found to be suppressed by increased complement activity, mediated by the production of IgM from spleen. However, this antibacterial activity disappeared when the E. coli were treated with complement-inactivated plasma obtained from splenoctomized rats. In addition, the resuscitation of HbVs from hemorrhagic shock increased the survival rate and viable bacterial counts in blood in cecum ligation and puncture rats, a sepsis model. In conclusion, the resuscitation of HbVs in the rat model of hemorrhagic shock suppresses bacterial growth via complement activation induced by IgM.

AB - Hemoglobin vesicles (HbVs) could serve as a substitute for red blood cells (RBCs) in resuscitation from massive hemorrhage. A massive transfusion of RBCs can increase the risk of infection, which is not caused by contaminating micro-organisms in the transfused RBCs but by a breakdown of the host defense system. We previously found that complement activity was increased after resuscitation with HbVs at a putative dose in a rat model of hemorrhagic shock. It is known that complement system plays a key role in host defense in the embryonic stage. Therefore, the objective of this study was to address whether the suppression of bacterial infections in hemorrhagic shock rats was a result of increased complement activity after massive HbV transfusion. For this purpose, Escherichia coli were incubated with plasma samples obtained from a rat model of hemorrhagic shock resuscitated by HbVs or RBCs, and bacterial growth was determined under ex vivo conditions. As a result, E. coli growth was found to be suppressed by increased complement activity, mediated by the production of IgM from spleen. However, this antibacterial activity disappeared when the E. coli were treated with complement-inactivated plasma obtained from splenoctomized rats. In addition, the resuscitation of HbVs from hemorrhagic shock increased the survival rate and viable bacterial counts in blood in cecum ligation and puncture rats, a sepsis model. In conclusion, the resuscitation of HbVs in the rat model of hemorrhagic shock suppresses bacterial growth via complement activation induced by IgM.

UR - http://www.scopus.com/inward/record.url?scp=79953016944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953016944&partnerID=8YFLogxK

U2 - 10.1124/jpet.110.177832

DO - 10.1124/jpet.110.177832

M3 - Article

C2 - 21228067

AN - SCOPUS:79953016944

VL - 337

SP - 201

EP - 208

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -